<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02520830</url>
  </required_header>
  <id_info>
    <org_study_id>Blueberries</org_study_id>
    <nct_id>NCT02520830</nct_id>
  </id_info>
  <brief_title>Effects of Blueberry-polyphenols on Endothelial Function, Absorption and Metabolism</brief_title>
  <official_title>Sustained Effects of Blueberry Polyphenols on Vascular Function in Healthy Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diets rich in fruits and vegetables have been linked to favorable cardiovascular outcomes in
      epidemiological studies.

      Dietary intervention studies with certain micronutrients have shown promising effects on
      surrogate parameters of vascular risk including blood pressure, endothelial function and
      cholesterol levels. Wild blueberries have gained attention due to their high content of
      phytochemicals and particularly anthocyanins. Whether wild blueberries can improve vascular
      function and health when given over relevant time periods and in relevant populations is not
      known. Therefore, it is the overall hypothesis of the study proposal that chronic consumption
      of wild blueberries can improve endothelial function, a prognostically validated surrogate of
      cardiovascular risk.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>baseline and 1 month</time_frame>
    <description>Determination of endothelial function by Flow mediated dilation (FMD) 0 and 2 hours postconsumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulse wave velocity</measure>
    <time_frame>baseline and 1 month</time_frame>
    <description>Measured by SphygmoCor 0 and 2 hours postconsumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>baseline and 1 month</time_frame>
    <description>automatical measurements, 0 and 2 hours postconsumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipids</measure>
    <time_frame>baseline and 1 month</time_frame>
    <description>biochemical analysis, 0 and 2 hours postconsumption</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Plasma blueberry polyphenol metabolites</measure>
    <time_frame>baseline and 1 month</time_frame>
    <description>measured by liquid chromotography- mass spectrometry (LC/MS) 0 and 2 hours postconsumption</description>
  </other_outcome>
  <other_outcome>
    <measure>Peripheral blood mononuclear cell-derived gene expression analysis</measure>
    <time_frame>baseline and 1 month</time_frame>
    <description>exploratory measures; measured by Agilent Human GZ 4x44 v2 Microarray</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Blueberry Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary Supplement: 22 gram freeze-dried blueberry powder per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>blueberry polyphenol deprived powder 22 gram per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Blueberry Group</intervention_name>
    <description>22 grams freeze-dried blueberry powder per day. Sustained intake (2x 11 grams daily over 1 month) of a drink consisting on freeze-dried wild blueberry powder dissolved in water</description>
    <arm_group_label>Blueberry Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo Group</intervention_name>
    <description>Sustained intake (2x 11 grams daily over 1 month) of a drink consisting in placebo powder dissolved in water</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy male subjects without clinical signs or symptoms of cardiovascular disease

          -  18-70 years

        Exclusion Criteria:

          -  cardiovascular disease

          -  acute inflammation

          -  cardiac arrhythmia

          -  renal failure

          -  heart failure (NYHA II-IV)

          -  diabetes mellitus

          -  C- reactive protein &gt; 1mg/dl

          -  malignant disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ana Rodriguez-Mateos, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Heiss, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonary Disease and Vascular Medicine, University Hospital Duesseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2015</study_first_submitted>
  <study_first_submitted_qc>August 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2015</study_first_posted>
  <last_update_submitted>November 2, 2015</last_update_submitted>
  <last_update_submitted_qc>November 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik f√ºr Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Dr. Ana Rodriguez Mateos</investigator_title>
  </responsible_party>
  <keyword>blueberry polyphenols</keyword>
  <keyword>Polyphenol metabolites</keyword>
  <keyword>endothelial function</keyword>
  <keyword>Molecular mechanisms of action</keyword>
  <keyword>Vascular function</keyword>
  <keyword>Healthy men</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

